| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |